1. Bringing care home
Molecule to Business
Huub Zijlstra -
Business Development Manager Healthcare
PostNL

2. Help patients in their
favorite environment
Mission

3. Economical Climate:
Pressure on costs in
Care & Cure
Aging, more health
needs
Renewed GDP
guidelines
Empowered patients
Personal medicines
Higher influence of
insurance
Merges in the sector
More high value medication
More Care & Cure at home
Developments & trends

4. Today
Every customer
is unique,
including the
distribution
requirements
Parcels
PostNL Pakketten
Pallets & Rolcages
PostNL Cargo
Behind the door
Extra@Home
Secured
Mikropakket
Courier
Valid Express
Temperature controlled
Pharma & Care
B2C fulfilment
Ecommerce Services

6. Regulation
1. Dutch Law: “Geneesmiddelenwet”
“handover” only by pharmacist (or doctor by exception)
2. GDP EU regulations (Good Distributions Practices):
• European perspective
• Dutch Healthcare Inspectorate
3. Pharmacist “standard”

7. Samenwerking
Orly Pharma & PostNL
What is important to OrlyPharma ?
1. GDP Compliancy
2. Price
3. Leadtimes
4. Temperature monitoring & qualitysystem
Good Distribution Practices (GDP)
“The required storage conditions for medicinal products
should be maintained during transportation within the
defined limits as described by the manufacturers or on the
outer packaging.”
GDP regulation, nov 2013, EU

8. Patient empowerment
Personal preferences
Patient journey

9. Health vs Logistics
Standard-
isation
High
educated
personal
Focus on
process
Product
knowledge
Communication

10. https://nl.linkedin.com/in/huubzijlstra
https://twitter.com/huubzijlstra
Business Development
Manager Healthcare
T: +31-622726810
E: huub.zijlstra@postnl.nl
Thank you for your
attention
Feel free to ask questions
and hopefully we meet along the
ride